Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04

AUTHORS

Mark Clemons, Sasha Mazzarello, John Hilton, Anil Joy, Julie Price-Hiller, Xiaofu Zhu, Shailendra Verma, Anne Kehoe, Mohammed FK Ibrahim, Marta Sienkiewicz, Carol Stober, Lisa Vandermeer, Brian Hutton, Ranjeeta Mallick, Dean Fergusson

ABSTRACT

PURPOSE: Optimal primary febrile neutropenia (FN) prophylaxis (i.e. ciprofloxacin or granulocyte-colony stimulating factors [G-CSF]) for patients receiving docetaxel-cyclophosphamide (TC) chemotherapy is unknown. We assessed the feasibility of using a novel pragmatic comparative effectiveness trial to compare these standard-of-care options. METHODS: Early-stage breast cancer patients receiving TC chemotherapy were randomised to either ciprofloxacin or G-CSF. Trial methodology consists of broad eligibility criteria, simply-defined endpoints, integrated consent model incorporating oral consent, and web-based randomisation in the clinic. Primary feasibility endpoints included patient and physician engagement (if > 50% of patients approached agree to participate and if > 50% of physicians approached patients for the study). Secondary clinical endpoints included the following: first occurrence rates of FN, treatment-related hospitalisation, or chemotherapy dose reduction/delay/discontinuation, as well as patient satisfaction with the oral consent process. RESULTS: Of 204 patients approached, 91.2% (186/204) agreed to randomisation. Sixteen of twenty (80%) participating medical oncologists randomised patients. Median patient age was 57.7 (range 31.8-84.1). The 186 patients received 557 cycles of chemotherapy. Overall incidences of first events by patient (n = 186) were as follows: FN (18/186, 21.43%), treatment-related hospitalisation (11/186, 13.10%), chemotherapy reduction (19/186, 22.62%), chemotherapy discontinuation (16/186, 19.05%), and chemotherapy delays (5/186, 5.95%). A total of 37.77% (69/186) of patients and 12.39% (69/557) of chemotherapy cycles had at least one of these first events. Patients were highly satisfied with the oral consent process. CONCLUSION: This study met its feasibility endpoints. This model offers a means of comparing standard-of-care treatments in a practical and cost-efficient manner. TRIAL REGISTRATION: Trial registration: ClinicalTrials.gov : NCT02173262. More... »

PAGES

1345-1354

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00520-018-4408-6

DOI

http://dx.doi.org/10.1007/s00520-018-4408-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1106117765

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30099602


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Ottawa Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412687.e", 
          "name": [
            "Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, The University of Ottawa, Ottawa, Canada", 
            "Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Canada", 
            "Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Clemons", 
        "givenName": "Mark", 
        "id": "sg:person.01216107435.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216107435.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ottawa Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412687.e", 
          "name": [
            "Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mazzarello", 
        "givenName": "Sasha", 
        "id": "sg:person.0737376756.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737376756.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ottawa Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412687.e", 
          "name": [
            "Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, The University of Ottawa, Ottawa, Canada", 
            "Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hilton", 
        "givenName": "John", 
        "id": "sg:person.01011642231.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011642231.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Alberta", 
          "id": "https://www.grid.ac/institutes/grid.17089.37", 
          "name": [
            "Division of Medical Oncology, Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Joy", 
        "givenName": "Anil", 
        "id": "sg:person.01131333657.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131333657.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Alberta", 
          "id": "https://www.grid.ac/institutes/grid.17089.37", 
          "name": [
            "Division of Medical Oncology, Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Price-Hiller", 
        "givenName": "Julie", 
        "id": "sg:person.01045242732.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045242732.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Alberta", 
          "id": "https://www.grid.ac/institutes/grid.17089.37", 
          "name": [
            "Division of Medical Oncology, Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhu", 
        "givenName": "Xiaofu", 
        "id": "sg:person.0762466520.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762466520.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, The University of Ottawa, Ottawa, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Verma", 
        "givenName": "Shailendra", 
        "id": "sg:person.01360400317.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360400317.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, The University of Ottawa, Ottawa, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kehoe", 
        "givenName": "Anne", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, The University of Ottawa, Ottawa, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ibrahim", 
        "givenName": "Mohammed FK", 
        "id": "sg:person.012754470322.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012754470322.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ottawa Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412687.e", 
          "name": [
            "Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sienkiewicz", 
        "givenName": "Marta", 
        "id": "sg:person.013516710304.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013516710304.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ottawa Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412687.e", 
          "name": [
            "Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stober", 
        "givenName": "Carol", 
        "id": "sg:person.012546702415.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012546702415.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ottawa Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412687.e", 
          "name": [
            "Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vandermeer", 
        "givenName": "Lisa", 
        "id": "sg:person.0761055556.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761055556.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ottawa Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412687.e", 
          "name": [
            "Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hutton", 
        "givenName": "Brian", 
        "id": "sg:person.01235465321.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235465321.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ottawa Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412687.e", 
          "name": [
            "Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mallick", 
        "givenName": "Ranjeeta", 
        "id": "sg:person.0657754474.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657754474.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ottawa Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412687.e", 
          "name": [
            "Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fergusson", 
        "givenName": "Dean", 
        "id": "sg:person.01152765352.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152765352.19"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ejca.2010.10.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006780383"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-011-1375-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017473885", 
          "https://doi.org/10.1007/s00520-011-1375-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.06.5391", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020781072"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2015.62.3488", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021783900"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-016-4028-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023282724", 
          "https://doi.org/10.1007/s10549-016-4028-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-016-4028-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023282724", 
          "https://doi.org/10.1007/s10549-016-4028-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3747/co.23.2394", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028514263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jop.2016.013474", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029512117"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.23.0508", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032930162"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2010.10.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034049872"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdq196", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034733668"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdq196", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034733668"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3747/co.v18i3.751", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037734300"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2014.4164", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037858442"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3747/co.20.1306", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038319021"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-004-1394-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038362411", 
          "https://doi.org/10.1007/s00125-004-1394-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-004-1394-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038362411", 
          "https://doi.org/10.1007/s00125-004-1394-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3747/co.v17i2.498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039793562"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.18.4028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047746487"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1472-6963-14-189", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050821717", 
          "https://doi.org/10.1186/1472-6963-14-189"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmhle1312508", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051027676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/153537020122600204", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074846877"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/153537020122600204", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074846877"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-017-4604-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1099700092", 
          "https://doi.org/10.1007/s10549-017-4604-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-017-4604-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1099700092", 
          "https://doi.org/10.1007/s10549-017-4604-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-018-4074-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100827000", 
          "https://doi.org/10.1007/s00520-018-4074-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-018-4074-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100827000", 
          "https://doi.org/10.1007/s00520-018-4074-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04", 
    "datePublishedReg": "2019-04-01", 
    "description": "PURPOSE: Optimal primary febrile neutropenia (FN) prophylaxis (i.e. ciprofloxacin or granulocyte-colony stimulating factors [G-CSF]) for patients receiving docetaxel-cyclophosphamide (TC) chemotherapy is unknown. We assessed the feasibility of using a novel pragmatic comparative effectiveness trial to compare these standard-of-care options.\nMETHODS: Early-stage breast cancer patients receiving TC chemotherapy were randomised to either ciprofloxacin or G-CSF. Trial methodology consists of broad eligibility criteria, simply-defined endpoints, integrated consent model incorporating oral consent, and web-based randomisation in the clinic. Primary feasibility endpoints included patient and physician engagement (if >\u200950% of patients approached agree to participate and if >\u200950% of physicians approached patients for the study). Secondary clinical endpoints included the following: first occurrence rates of FN, treatment-related hospitalisation, or chemotherapy dose reduction/delay/discontinuation, as well as patient satisfaction with the oral consent process.\nRESULTS: Of 204 patients approached, 91.2% (186/204) agreed to randomisation. Sixteen of twenty (80%) participating medical oncologists randomised patients. Median patient age was 57.7 (range 31.8-84.1). The 186 patients received 557 cycles of chemotherapy. Overall incidences of first events by patient (n\u2009=\u2009186) were as follows: FN (18/186, 21.43%), treatment-related hospitalisation (11/186, 13.10%), chemotherapy reduction (19/186, 22.62%), chemotherapy discontinuation (16/186, 19.05%), and chemotherapy delays (5/186, 5.95%). A total of 37.77% (69/186) of patients and 12.39% (69/557) of chemotherapy cycles had at least one of these first events. Patients were highly satisfied with the oral consent process.\nCONCLUSION: This study met its feasibility endpoints. This model offers a means of comparing standard-of-care treatments in a practical and cost-efficient manner.\nTRIAL REGISTRATION: Trial registration: ClinicalTrials.gov : NCT02173262.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00520-018-4408-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1103473", 
        "issn": [
          "0941-4355", 
          "1433-7339"
        ], 
        "name": "Supportive Care in Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "27"
      }
    ], 
    "name": "Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC)", 
    "pagination": "1345-1354", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "0f8b1db792428222b0a5340ad1bb1733d883d987830abbda6b5f09970b70c975"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30099602"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9302957"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00520-018-4408-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1106117765"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00520-018-4408-6", 
      "https://app.dimensions.ai/details/publication/pub.1106117765"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000348_0000000348/records_54322_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00520-018-4408-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00520-018-4408-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00520-018-4408-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00520-018-4408-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00520-018-4408-6'


 

This table displays all metadata directly associated to this object as RDF triples.

246 TRIPLES      21 PREDICATES      50 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00520-018-4408-6 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N28b5a89988624768bf76fc8080a24554
4 schema:citation sg:pub.10.1007/s00125-004-1394-7
5 sg:pub.10.1007/s00520-011-1375-6
6 sg:pub.10.1007/s00520-018-4074-8
7 sg:pub.10.1007/s10549-016-4028-0
8 sg:pub.10.1007/s10549-017-4604-y
9 sg:pub.10.1186/1472-6963-14-189
10 https://doi.org/10.1001/jama.2014.4164
11 https://doi.org/10.1016/j.ejca.2010.10.001
12 https://doi.org/10.1016/j.ejca.2010.10.013
13 https://doi.org/10.1056/nejmhle1312508
14 https://doi.org/10.1093/annonc/mdq196
15 https://doi.org/10.1177/153537020122600204
16 https://doi.org/10.1200/jco.2006.06.5391
17 https://doi.org/10.1200/jco.2008.18.4028
18 https://doi.org/10.1200/jco.2009.23.0508
19 https://doi.org/10.1200/jco.2015.62.3488
20 https://doi.org/10.1200/jop.2016.013474
21 https://doi.org/10.3747/co.20.1306
22 https://doi.org/10.3747/co.23.2394
23 https://doi.org/10.3747/co.v17i2.498
24 https://doi.org/10.3747/co.v18i3.751
25 schema:datePublished 2019-04
26 schema:datePublishedReg 2019-04-01
27 schema:description PURPOSE: Optimal primary febrile neutropenia (FN) prophylaxis (i.e. ciprofloxacin or granulocyte-colony stimulating factors [G-CSF]) for patients receiving docetaxel-cyclophosphamide (TC) chemotherapy is unknown. We assessed the feasibility of using a novel pragmatic comparative effectiveness trial to compare these standard-of-care options. METHODS: Early-stage breast cancer patients receiving TC chemotherapy were randomised to either ciprofloxacin or G-CSF. Trial methodology consists of broad eligibility criteria, simply-defined endpoints, integrated consent model incorporating oral consent, and web-based randomisation in the clinic. Primary feasibility endpoints included patient and physician engagement (if > 50% of patients approached agree to participate and if > 50% of physicians approached patients for the study). Secondary clinical endpoints included the following: first occurrence rates of FN, treatment-related hospitalisation, or chemotherapy dose reduction/delay/discontinuation, as well as patient satisfaction with the oral consent process. RESULTS: Of 204 patients approached, 91.2% (186/204) agreed to randomisation. Sixteen of twenty (80%) participating medical oncologists randomised patients. Median patient age was 57.7 (range 31.8-84.1). The 186 patients received 557 cycles of chemotherapy. Overall incidences of first events by patient (n = 186) were as follows: FN (18/186, 21.43%), treatment-related hospitalisation (11/186, 13.10%), chemotherapy reduction (19/186, 22.62%), chemotherapy discontinuation (16/186, 19.05%), and chemotherapy delays (5/186, 5.95%). A total of 37.77% (69/186) of patients and 12.39% (69/557) of chemotherapy cycles had at least one of these first events. Patients were highly satisfied with the oral consent process. CONCLUSION: This study met its feasibility endpoints. This model offers a means of comparing standard-of-care treatments in a practical and cost-efficient manner. TRIAL REGISTRATION: Trial registration: ClinicalTrials.gov : NCT02173262.
28 schema:genre research_article
29 schema:inLanguage en
30 schema:isAccessibleForFree false
31 schema:isPartOf N0482dc4449fb4efd98ec4ea480b6dca3
32 Nbdf4bf7b64bf456c9076d6bda3c1a7d9
33 sg:journal.1103473
34 schema:name Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC)
35 schema:pagination 1345-1354
36 schema:productId N1444a74ef1e04a9aa7397d20882cab1a
37 N3b29c825f88c41cd8c57adfc90b26eab
38 N7fbc02784c154ce89c228c8695624999
39 N9217f2e5291943468cd15d6e3e155908
40 Nc81e587b04944a7c8df55143dad7a9dd
41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106117765
42 https://doi.org/10.1007/s00520-018-4408-6
43 schema:sdDatePublished 2019-04-11T10:19
44 schema:sdLicense https://scigraph.springernature.com/explorer/license/
45 schema:sdPublisher N4706e8d6b547440c83e529915b2cd339
46 schema:url https://link.springer.com/10.1007%2Fs00520-018-4408-6
47 sgo:license sg:explorer/license/
48 sgo:sdDataset articles
49 rdf:type schema:ScholarlyArticle
50 N0482dc4449fb4efd98ec4ea480b6dca3 schema:volumeNumber 27
51 rdf:type schema:PublicationVolume
52 N135b35f79a634415b6250661760f739d schema:name Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, The University of Ottawa, Ottawa, Canada
53 rdf:type schema:Organization
54 N1444a74ef1e04a9aa7397d20882cab1a schema:name dimensions_id
55 schema:value pub.1106117765
56 rdf:type schema:PropertyValue
57 N1f8953727c254cf5bd34e463710cadb7 rdf:first sg:person.012754470322.02
58 rdf:rest Na074c53a7a1f4964bc92bd30e1e8f387
59 N20a1d16e486e4ee4a16cf3ee5488760e rdf:first sg:person.01011642231.93
60 rdf:rest N316bbe470ebc416bbf09aa2507f529eb
61 N28b5a89988624768bf76fc8080a24554 rdf:first sg:person.01216107435.90
62 rdf:rest N6150de472e6942809f99d78542b684a9
63 N316bbe470ebc416bbf09aa2507f529eb rdf:first sg:person.01131333657.06
64 rdf:rest Nfa9af1edd277400e90d79a32ec31b7e6
65 N33fc724226ae4286b75e271e97c89dae schema:name Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, The University of Ottawa, Ottawa, Canada
66 rdf:type schema:Organization
67 N3b29c825f88c41cd8c57adfc90b26eab schema:name doi
68 schema:value 10.1007/s00520-018-4408-6
69 rdf:type schema:PropertyValue
70 N466749bacfaf49849910f36d59bb8333 schema:affiliation Nfd0775326ed644b5a969daa50496b800
71 schema:familyName Kehoe
72 schema:givenName Anne
73 rdf:type schema:Person
74 N4706e8d6b547440c83e529915b2cd339 schema:name Springer Nature - SN SciGraph project
75 rdf:type schema:Organization
76 N4e8a9b027ce54228ae80b2c2ed40590e rdf:first sg:person.01235465321.38
77 rdf:rest N9679ee27afff421c87ad9d7217642aca
78 N5cc3d23112954a62bc83ed5e9708d04a rdf:first sg:person.0761055556.65
79 rdf:rest N4e8a9b027ce54228ae80b2c2ed40590e
80 N6150de472e6942809f99d78542b684a9 rdf:first sg:person.0737376756.24
81 rdf:rest N20a1d16e486e4ee4a16cf3ee5488760e
82 N73ab522cec444725b25fbbdd89592be5 rdf:first N466749bacfaf49849910f36d59bb8333
83 rdf:rest N1f8953727c254cf5bd34e463710cadb7
84 N7c9828fdbc444b899ab8e0a6c50d7f55 rdf:first sg:person.01152765352.19
85 rdf:rest rdf:nil
86 N7fbc02784c154ce89c228c8695624999 schema:name nlm_unique_id
87 schema:value 9302957
88 rdf:type schema:PropertyValue
89 N9217f2e5291943468cd15d6e3e155908 schema:name pubmed_id
90 schema:value 30099602
91 rdf:type schema:PropertyValue
92 N93ba8f7d7f294db987153c1d63df564e rdf:first sg:person.012546702415.53
93 rdf:rest N5cc3d23112954a62bc83ed5e9708d04a
94 N9679ee27afff421c87ad9d7217642aca rdf:first sg:person.0657754474.04
95 rdf:rest N7c9828fdbc444b899ab8e0a6c50d7f55
96 Na074c53a7a1f4964bc92bd30e1e8f387 rdf:first sg:person.013516710304.84
97 rdf:rest N93ba8f7d7f294db987153c1d63df564e
98 Nbdf4bf7b64bf456c9076d6bda3c1a7d9 schema:issueNumber 4
99 rdf:type schema:PublicationIssue
100 Nc81e587b04944a7c8df55143dad7a9dd schema:name readcube_id
101 schema:value 0f8b1db792428222b0a5340ad1bb1733d883d987830abbda6b5f09970b70c975
102 rdf:type schema:PropertyValue
103 Nf2707f7f11fc449098edc98a4df3ef47 rdf:first sg:person.0762466520.22
104 rdf:rest Nf28e91d9e9c04d70bfe17d0f2409e373
105 Nf28e91d9e9c04d70bfe17d0f2409e373 rdf:first sg:person.01360400317.21
106 rdf:rest N73ab522cec444725b25fbbdd89592be5
107 Nfa9af1edd277400e90d79a32ec31b7e6 rdf:first sg:person.01045242732.75
108 rdf:rest Nf2707f7f11fc449098edc98a4df3ef47
109 Nfd0775326ed644b5a969daa50496b800 schema:name Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, The University of Ottawa, Ottawa, Canada
110 rdf:type schema:Organization
111 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
112 schema:name Medical and Health Sciences
113 rdf:type schema:DefinedTerm
114 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
115 schema:name Oncology and Carcinogenesis
116 rdf:type schema:DefinedTerm
117 sg:journal.1103473 schema:issn 0941-4355
118 1433-7339
119 schema:name Supportive Care in Cancer
120 rdf:type schema:Periodical
121 sg:person.01011642231.93 schema:affiliation https://www.grid.ac/institutes/grid.412687.e
122 schema:familyName Hilton
123 schema:givenName John
124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011642231.93
125 rdf:type schema:Person
126 sg:person.01045242732.75 schema:affiliation https://www.grid.ac/institutes/grid.17089.37
127 schema:familyName Price-Hiller
128 schema:givenName Julie
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045242732.75
130 rdf:type schema:Person
131 sg:person.01131333657.06 schema:affiliation https://www.grid.ac/institutes/grid.17089.37
132 schema:familyName Joy
133 schema:givenName Anil
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131333657.06
135 rdf:type schema:Person
136 sg:person.01152765352.19 schema:affiliation https://www.grid.ac/institutes/grid.412687.e
137 schema:familyName Fergusson
138 schema:givenName Dean
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152765352.19
140 rdf:type schema:Person
141 sg:person.01216107435.90 schema:affiliation https://www.grid.ac/institutes/grid.412687.e
142 schema:familyName Clemons
143 schema:givenName Mark
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216107435.90
145 rdf:type schema:Person
146 sg:person.01235465321.38 schema:affiliation https://www.grid.ac/institutes/grid.412687.e
147 schema:familyName Hutton
148 schema:givenName Brian
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235465321.38
150 rdf:type schema:Person
151 sg:person.012546702415.53 schema:affiliation https://www.grid.ac/institutes/grid.412687.e
152 schema:familyName Stober
153 schema:givenName Carol
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012546702415.53
155 rdf:type schema:Person
156 sg:person.012754470322.02 schema:affiliation N135b35f79a634415b6250661760f739d
157 schema:familyName Ibrahim
158 schema:givenName Mohammed FK
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012754470322.02
160 rdf:type schema:Person
161 sg:person.013516710304.84 schema:affiliation https://www.grid.ac/institutes/grid.412687.e
162 schema:familyName Sienkiewicz
163 schema:givenName Marta
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013516710304.84
165 rdf:type schema:Person
166 sg:person.01360400317.21 schema:affiliation N33fc724226ae4286b75e271e97c89dae
167 schema:familyName Verma
168 schema:givenName Shailendra
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360400317.21
170 rdf:type schema:Person
171 sg:person.0657754474.04 schema:affiliation https://www.grid.ac/institutes/grid.412687.e
172 schema:familyName Mallick
173 schema:givenName Ranjeeta
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657754474.04
175 rdf:type schema:Person
176 sg:person.0737376756.24 schema:affiliation https://www.grid.ac/institutes/grid.412687.e
177 schema:familyName Mazzarello
178 schema:givenName Sasha
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737376756.24
180 rdf:type schema:Person
181 sg:person.0761055556.65 schema:affiliation https://www.grid.ac/institutes/grid.412687.e
182 schema:familyName Vandermeer
183 schema:givenName Lisa
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761055556.65
185 rdf:type schema:Person
186 sg:person.0762466520.22 schema:affiliation https://www.grid.ac/institutes/grid.17089.37
187 schema:familyName Zhu
188 schema:givenName Xiaofu
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762466520.22
190 rdf:type schema:Person
191 sg:pub.10.1007/s00125-004-1394-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038362411
192 https://doi.org/10.1007/s00125-004-1394-7
193 rdf:type schema:CreativeWork
194 sg:pub.10.1007/s00520-011-1375-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017473885
195 https://doi.org/10.1007/s00520-011-1375-6
196 rdf:type schema:CreativeWork
197 sg:pub.10.1007/s00520-018-4074-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100827000
198 https://doi.org/10.1007/s00520-018-4074-8
199 rdf:type schema:CreativeWork
200 sg:pub.10.1007/s10549-016-4028-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023282724
201 https://doi.org/10.1007/s10549-016-4028-0
202 rdf:type schema:CreativeWork
203 sg:pub.10.1007/s10549-017-4604-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1099700092
204 https://doi.org/10.1007/s10549-017-4604-y
205 rdf:type schema:CreativeWork
206 sg:pub.10.1186/1472-6963-14-189 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050821717
207 https://doi.org/10.1186/1472-6963-14-189
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1001/jama.2014.4164 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037858442
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1016/j.ejca.2010.10.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006780383
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1016/j.ejca.2010.10.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034049872
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1056/nejmhle1312508 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051027676
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1093/annonc/mdq196 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034733668
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1177/153537020122600204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074846877
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1200/jco.2006.06.5391 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020781072
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1200/jco.2008.18.4028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047746487
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1200/jco.2009.23.0508 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032930162
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1200/jco.2015.62.3488 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021783900
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1200/jop.2016.013474 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029512117
230 rdf:type schema:CreativeWork
231 https://doi.org/10.3747/co.20.1306 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038319021
232 rdf:type schema:CreativeWork
233 https://doi.org/10.3747/co.23.2394 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028514263
234 rdf:type schema:CreativeWork
235 https://doi.org/10.3747/co.v17i2.498 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039793562
236 rdf:type schema:CreativeWork
237 https://doi.org/10.3747/co.v18i3.751 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037734300
238 rdf:type schema:CreativeWork
239 https://www.grid.ac/institutes/grid.17089.37 schema:alternateName University of Alberta
240 schema:name Division of Medical Oncology, Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Canada
241 rdf:type schema:Organization
242 https://www.grid.ac/institutes/grid.412687.e schema:alternateName Ottawa Hospital
243 schema:name Cancer Research Program, The Ottawa Hospital Research Institute, Ottawa, Canada
244 Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada
245 Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, The University of Ottawa, Ottawa, Canada
246 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...